Neurolutions wins breakthrough nod for stroke rehab device

The FDA announced today that it authorized the Neurolutions IpsiHand upper extremity rehabilitation system for stroke rehab.

Approval encompasses patients 18 years of age and older who are undergoing stroke rehabilitation to facilitate muscle re-education and need to maintain or increase their range of motion, according to a news release. It is a brain-computer-interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity or hand, wrist and arm disability.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Neurolutions wins breakthrough nod for stroke rehab device

The FDA announced today that it authorized the Neurolutions IpsiHand upper extremity rehabilitation system for stroke rehab.

Approval encompasses patients 18 years of age and older who are undergoing stroke rehabilitation to facilitate muscle re-education and need to maintain or increase their range of motion, according to a news release. It is a brain-computer-interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity or hand, wrist and arm disability.

IpsiHand uses non-invasive electroencephalography (EEG) electrodes — instead of an implanted electrode or other invasive feature — to record brain activity. EEG data is then wirelessly transmitted to a tablet for analysis of the intended motor function and the signal is sent to a wireless electronic hand brace designed to move the patient’s hand.

The aim of the device is to help stroke patients improve grasping with their hands. It is currently prescription-only a…

Read more
  • 0